These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 6134748)
21. Relationship between potency of blocking type thyrotropin-binding inhibitor immunoglobulin in three women with primary myxedema and thyroid function of their neonates. Inomata H; Sasaki N; Tamaru K; Ushiku H; Niimi H; Nakajima H Endocrinol Jpn; 1986 Jun; 33(3):353-9. PubMed ID: 3019652 [TBL] [Abstract][Full Text] [Related]
22. A predicted case with neonatal transient hypothyroidism due to blocking type thyrotropin binding inhibitor immunoglobulins (TBII). Ishihara T; Waseda N; Ikekubo K; Kuroda K; Akamizu T; Mori T Endocrinol Jpn; 1985 Feb; 32(1):189-94. PubMed ID: 2990883 [TBL] [Abstract][Full Text] [Related]
24. [Studies on the radioreceptor assay of TSH: the properties of TSH-binding inhibitor immunoglobulins (TBII) in patients with Hashimoto's thyroiditis (author's transl)]. Endo K Nihon Naibunpi Gakkai Zasshi; 1979 Oct; 55(10):1275-85. PubMed ID: 228999 [TBL] [Abstract][Full Text] [Related]
25. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment. Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520 [TBL] [Abstract][Full Text] [Related]
26. Thyrotropin binding inhibiting immunoglobulins (TBII) in Graves' disease, toxic nodular goitre and autoimmune thyroiditis. Wägar G; Mäkinen T; Lamberg BA; Gordin A; Apter L; Pekonen F Ann Clin Res; 1982 Apr; 14(2):83-9. PubMed ID: 6184007 [TBL] [Abstract][Full Text] [Related]
27. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease. Orgiazzi J; Williams DE; Chopra IJ; Solomon DH J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604 [TBL] [Abstract][Full Text] [Related]
29. Pregnancy induces the presence of a thyroid-stimulating antibody in a thyrotropin-binding inhibitory immunoglobulin positive, hypothyroid woman with transient thyrotoxicosis in offspring. Chang TC; Lee JS J Formos Med Assoc; 1990 Aug; 89(8):709-13. PubMed ID: 1981235 [TBL] [Abstract][Full Text] [Related]
30. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities. Tamaki H; Amino N; Watanabe Y; Aozasa M; Hayashi H; Tachi J; Miyai K J Clin Lab Immunol; 1986 May; 20(1):1-6. PubMed ID: 3016274 [TBL] [Abstract][Full Text] [Related]
31. Detection of thyrotropin binding inhibitory activity in neonatal blood spots. Brown RS; Bellisario RL; Mitchell E; Keating P; Botero D J Clin Endocrinol Metab; 1993 Oct; 77(4):1005-8. PubMed ID: 8104953 [TBL] [Abstract][Full Text] [Related]
32. Humoral thyroid autoimmunity is not involved in the pathogenesis of myxedematous endemic cretinism. Chiovato L; Vitti P; Bendinelli G; Santini F; Fiore E; Tonacchera M; Mammoli C; Capaccioli A; Venturi S; Pretell E J Clin Endocrinol Metab; 1995 May; 80(5):1509-14. PubMed ID: 7744994 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of thyrotropin-induced adenosine 3'5'-monophosphate increase by immunoglobulins from patients with primary myxedema. Konishi J; Iida Y; Endo K; Misaki T; Nohara Y; Matsuura N; Mori T; Torizuka K J Clin Endocrinol Metab; 1983 Sep; 57(3):544-9. PubMed ID: 6135705 [TBL] [Abstract][Full Text] [Related]
34. Two types of thyroid function-blocking antibodies in autoimmune atrophic thyroiditis and transient neonatal hypothyroidism due to maternal IgG. Takasu N; Naka M; Mori T; Yamada T Clin Endocrinol (Oxf); 1984 Oct; 21(4):345-55. PubMed ID: 6096043 [TBL] [Abstract][Full Text] [Related]
35. The interaction of thyrotrophin binding inhibiting immunoglobulins with high and low affinity TSH receptors. Pekonen F; Mäkinen T Acta Endocrinol Suppl (Copenh); 1983; 251():33-7. PubMed ID: 6132509 [TBL] [Abstract][Full Text] [Related]
36. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells. Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672 [TBL] [Abstract][Full Text] [Related]
37. Maternal TSH-receptor antibodies and TSH antibodies in screening for congenital hypothyroidism. Karlsson FA; Dahlberg PA; Alm J; Larsson A; Felding I Acta Paediatr Scand; 1986 Sep; 75(5):756-61. PubMed ID: 3564943 [TBL] [Abstract][Full Text] [Related]
38. Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan. Tamaki H; Amino N; Kimura M; Hidaka Y; Takeoka K; Miyai K J Clin Endocrinol Metab; 1990 Nov; 71(5):1382-6. PubMed ID: 1977757 [TBL] [Abstract][Full Text] [Related]
39. Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease. Kohn LD; Suzuki K; Hoffman WH; Tombaccini D; Marcocci C; Shimojo N; Watanabe Y; Amino N; Cho BY; Kohno Y; Hirai A; Tahara K J Clin Endocrinol Metab; 1997 Dec; 82(12):3998-4009. PubMed ID: 9398703 [TBL] [Abstract][Full Text] [Related]
40. Neonatal thyroid disease: differential expression in three successive offspring. Fort P; Lifshitz F; Pugliese M; Klein I J Clin Endocrinol Metab; 1988 Mar; 66(3):645-7. PubMed ID: 2895120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]